Less robust in a sense that only high dose 600mg in final report is in line with interim result from all dose group. That's all I can find. VRTX really handled the data release very badly, both times. Consider problem they had with interim release, they should release all data from final.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.